Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article 'Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial'
Eur J Heart Fail
.
2020 Oct;22(10):1934-1935.
doi: 10.1002/ejhf.1852.
Epub 2020 Apr 30.
Authors
Alberto Aimo
1
2
,
Vincenzo Castiglione
1
2
,
Carlo Mario Lombardi
3
Affiliations
1
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
2
Cardiology Division, University Hospital of Pisa, Italy.
3
Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University and Civil Hospital, Brescia, Italy.
PMID:
32353173
DOI:
10.1002/ejhf.1852
No abstract available
Publication types
Letter
Comment
MeSH terms
Heart Failure* / drug therapy
Heart Failure* / epidemiology
Heterocyclic Compounds, 2-Ring*
Humans
Pyrimidines
Stroke Volume
Substances
Heterocyclic Compounds, 2-Ring
Pyrimidines
vericiguat